Conference Chair
Michael Graner
Associate Professor, University of Colorado Anschutz School of Medicine |
Keynote Speakers
Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated | 
Paul Robbins
Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology | 
Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University | 
Susanne Gabrielsson
Professor, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet | 
Samir EL-Andaloussi
Associate Professor, Karolinska Institutet |
|
Aijun Wang
Associate Professor, Director of Translational Research, Innovation and Entrepreneurship, University of California-Davis | 
Lorraine O’Driscoll
Professor in Pharmacology, Trinity College Dublin | 
Jennifer Jones
Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI) | 
Dana Larocca
VP Discovery Research, AgeX Therapeutics | 
Steven Stice
Co-Founder and Chief Scientific Officer, Aruna Bio; DW Brook Distinguished Professor and Director of the Regenerative Bioscience Center, Georgia Research Alliance Eminent Scholar, University of Georgia | 
Raghu Kalluri
Professor & Chairman, Department of Cancer Biology; Olla S. Stribling Distinguished Chair for Cancer Research, MD Anderson Cancer Center | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Mei He
Assistant Professor, University of Kansas | 
Jan Lotvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles | 
Dolores Di Vizio
Professor, Cedars Sinai Medical Center |
OverviewSelectBIO EV-based Diagnostics, Delivery & Therapeutics 2020 Conference brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
- Exosome/EV Engineering -- Engineered Exosomes for Delivery
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date.
Registered
delegates receive access to the co-located concurrent conference
tracks, the co-located exhibit hall featuring companies from around the
world providing tools/technologies, products and services.
Conference Presentations and Content Organization
- Circulating Biomarkers 2020
- EV-based Diagnostics, Delivery and Therapeutics 2020
- EVs and Stem Cells Summit 2020 -- Speakers from this Track are in the Two Co-Located Tracks
Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 31 January 2020 Agenda Topics- Engineered Exosomes and Extracellular Vesicles (EVs) for Delivery
- Engineering EVs as Biologic Drugs
- Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
- Exosomes-based Diagnostics/Liquid Biopsy Development
- Diagnostics Markers Carried by Exosomes
- Liquid Biopsy Enabled by Analyzing Exosomes
- Exosomes/EVs-based Drug Delivery
- Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
- Stem Cell-based EVs for Regenerative Medicine
Sponsorship and Exhibition OpportunitiesFor more details, please contact us.
|
Confirmed Speakers to date
Tom Anchordoquy, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Fatah Kashanchi, Professor, George Mason University
Aurelio Lorico, Professor of Pathology, Touro University Nevada
My Mahoney, Associate Professor, Thomas Jefferson University
Juliane Nguyen, Associate Professor, University of North Carolina at Chapel Hill
Robert Raffai, Professor, University of California-San Francisco
Davide Trotti, Professor, Scientific Director, Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University
Kendall Van Keuren-Jensen, Associate Professor, Translational Genomics Research Institute
William Whitford, Strategic Solutions Leader, GE Healthcare Life Sciences
Andries Zijlstra, Associate Professor of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
